Home » Topics » Disease categories and therapies » Endocrine/metabolic

Endocrine/metabolic
RSS

Lilly claims compounds for postmenopausal syndrome

Feb. 26, 1997

Hemosol's blood substitute advances to phase II

Feb. 25, 1997

Agents for infertility described by Novo Nordisk

Feb. 25, 1997

GH-releasing peptides from Novo Nordisk

Feb. 25, 1997

Novo Nordisk's growth hormone now available in 67 countries

Feb. 24, 1997

Merck's Fosamax earns recommendation

Feb. 24, 1997

SKB prepares chimeric leptins

Feb. 20, 1997

Indian investigators prepare novel hypolipidemic agents

Feb. 20, 1997

New ACAT inhibitor associated with diarrhea

Feb. 19, 1997

First launch for lipid-lowering statin

Feb. 19, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 10, 2026.
‘Target-high but uptake-defective’ state identified in ADC resistance
BioWorld
Separate research teams have reported new insights into resistance mechanisms to the antibody-drug conjugate (ADC) Padcev (enfortumab vedotin, Astellas Pharma...
Ionis, AZ shares down on unexpected Wainua flop in cardiomyopathy
BioWorld
News of the unexpected phase III failure of the gene silencing drug Wainua (eplontersen) in the treatment of transthyretin-mediated amyloid cardiomyopathy sent...
FENS 2026: Shedding light on the sheddome
BioWorld
At the recently opened FENS Forum 2026 in Barcelona – the Federation of European Neuroscience Societies’ flagship congress and Europe’s largest neuroscience...
FENS 2026: Next-gen biologics take on brain disease
BioWorld
Whether by fine-tuning neurotransmitter signaling or silencing disease-associated genes, emerging biologic therapies are reshaping neuroscience drug development,...